Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Supplemental material
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Open Access | 10.1172/JCI205881

Corrigendum to Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction

Seung-Jun Lee, Choong-kun Lee, Seok Kang, Intae Park, Yoo Hyung Kim, Seo Ki Kim, Seon Pyo Hong, Hosung Bae, Yulong He, Yoshiaki Kubota, and Gou Young Koh

Find articles by Lee, S. in: PubMed | Google Scholar

Find articles by Lee, C. in: PubMed | Google Scholar

Find articles by Kang, S. in: PubMed | Google Scholar

Find articles by Park, I. in: PubMed | Google Scholar

Find articles by Kim, Y. in: PubMed | Google Scholar

Find articles by Kim, S. in: PubMed | Google Scholar

Find articles by Hong, S. in: PubMed | Google Scholar |

Find articles by Bae, H. in: PubMed | Google Scholar |

Find articles by He, Y. in: PubMed | Google Scholar

Find articles by Kubota, Y. in: PubMed | Google Scholar |

Find articles by Koh, G. in: PubMed | Google Scholar

Published April 1, 2026 - More info

Published in Volume 136, Issue 7 on April 1, 2026
J Clin Invest. 2026;136(7):e205881. https://doi.org/10.1172/JCI205881.
© 2026 Lee et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 1, 2026 - Version history
View PDF

Related article:

Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Seung-Jun Lee, Choong-kun Lee, Seok Kang, Intae Park, Yoo Hyung Kim, Seo Ki Kim, Seon Pyo Hong, Hosung Bae, Yulong He, Yoshiaki Kubota, Gou Young Koh
Seung-Jun Lee, Choong-kun Lee, Seok Kang, Intae Park, Yoo Hyung Kim, Seo Ki Kim, Seon Pyo Hong, Hosung Bae, Yulong He, Yoshiaki Kubota, Gou Young Koh
Research Article Cardiology Vascular biology

Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction

  • Text
  • PDF
Abstract

Emerging evidence indicates that angiopoietin-2 (Angpt2), a well-recognized vascular destabilizing factor, is a biomarker of poor outcome in ischemic heart disease. However, its precise role in postischemic cardiovascular remodeling is poorly understood. Here, we show that Angpt2 plays multifaceted roles in the exacerbation of cardiac hypoxia and inflammation after myocardial ischemia. Angpt2 was highly expressed in endothelial cells at the infarct border zone after myocardial infarction (MI) or ischemia/reperfusion injury in mice. In the acute phase of MI, endothelial-derived Angpt2 antagonized Angpt1/Tie2 signaling, which was greatly involved in pericyte detachment, vascular leakage, increased adhesion molecular expression, degradation of the glycocalyx and extracellular matrix, and enhanced neutrophil infiltration and hypoxia in the infarct border area. In the chronic remodeling phase after MI, endothelial- and macrophage-derived Angpt2 continuously promoted abnormal vascular remodeling and proinflammatory macrophage polarization through integrin α5β1 signaling, worsening cardiac hypoxia and inflammation. Accordingly, inhibition of Angpt2 either by gene deletion or using an anti-Angpt2 blocking antibody substantially alleviated these pathological findings and ameliorated postischemic cardiovascular remodeling. Blockade of Angpt2 thus has potential as a therapeutic option for ischemic heart failure.

Authors

Seung-Jun Lee, Choong-kun Lee, Seok Kang, Intae Park, Yoo Hyung Kim, Seo Ki Kim, Seon Pyo Hong, Hosung Bae, Yulong He, Yoshiaki Kubota, Gou Young Koh

×

Original citation: J Clin Invest. 2018;128(11):5018–5033. https://doi.org/10.1172/JCI99659

Citation for this corrigendum: J Clin Invest. 2026;136(7):e205881. https://doi.org/10.1172/JCI205881

The authors recently became aware of the following errors in the original manuscript: In Figure 7K, the ATN-161 image was incorrect and was derived from the same sample as the Figure 7H WT image; in Supplemental Figure 6B, the WT TER119/NG2/CD31 image was incorrect and was derived from the same sample as the Supplemental 6B Tie2iΔEC TER119/NG2/CD31 image; in Supplemental Figure 8B, the MI 3d images were incorrect and were derived from the same samples as Figure 6E Angpt2iΔEC; in Supplemental Figure 11A, the Sham ZO1/CD31 image was incorrect and was derived from the same sample as Figure 9D Sham FITC-Lectin/CD31; and in Supplemental Figure 13A, the I/R 7d Angpt2/CD31 image was incorrect and was derived from the same sample as shown in Figure 3F. The authors confirmed that the quantitative data accompanying these errors were obtained independently and were unaffected by the corrections. The legend for Supplemental Figure 8B was also updated for clarity and accuracy. The corrected figures, based on the original source data, are provided below and in the updated supplemental materials. The HTML and PDF versions of the paper have been updated.

Angpt2/integrin α5β1 signaling is positively associated with pERK expressioFigure 7

Angpt2/integrin α5β1 signaling is positively associated with pERK expression in macrophages in ischemic heart.

The authors regret the errors.

Supplemental material

View Supplemental data

Footnotes

See the related article at Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.

Version history
  • Version 1 (April 1, 2026): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Supplemental material
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts